Fidelity SPDR Advertisement
Home > Boards > US OTC > Delisted >

Radient Pharmaceuticals Corporation (fka RXPC)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Gold Seeker, jimtash, Peggy
Search This Board:
Last Post: 9/20/2014 8:32:10 PM - Followers: 223 - Board type: Free - Posts Today: 0
Provistadx has repeatedly denied any connection with Radient Pharmaceuticals.

William Gartner of GCDx denies any connection with Radient Pharmaceuticals.

Dear Mr. Gartner,

I am intrigued by your recent press release about offering a new Lung Cancer Test.

How do you get your financing? Is there an opportunity for a private investor like me to invest, and if so, how would I accomplish that?

In researching GCDx, I am finding several rumors on the internet (particularly on that your company is merging with, or taking over, Radient Pharmaceuticals and/or Provista Diagnostics. Is there any truth to that rumor? What is your current business relationship with Radient Pharmaceuticals and Provista Diagnostics? Do you own RXPC stock?

I am concerned that Radient might be carrying a lot of debt -- if you are involved with taking over or merging with Radient, what kind of debt responsibilities are you incurring, and if I invest in your company, how would I know that my money is not going towards paying off Radient's debt?

Finally -- do you have any patents or patent applications for The Lung Cancer Test for Early Detection?

Thank you for your time,


Good morning,

Before I answer all of your questions, I need to know more about you, especially whether or not you are a qualified investor under Rule 144. I will say this to clear up that very old rumor. We have no connection whatsoever with Radient Pharmaceutical in any way – company-wise or personally.

Do you represent a firm or is this personal? We must be very careful to comply with all of the regulations.


William Gartner

President and CEO

Global Cancer Diagnostics Inc.

2343 W. University Dr.

Suite 105

Tempe, Arizona 85281 USA

602-908-9604 Office

602-300-4901 Cell

Onko-Sure™ is a simple, non-invasive blood test, which targets a cancer-caused breakdown product. Onko-Sure™ detects a tumor marker that is associated with most cancers. The biological target for the Onko-Sure™ test is abundant and floats-freely in blood (unlike Carcinoembryonic antigen, CEA). Biomarker levels rise dramatically with cancer progression (up to 38 times greater than in normal patients). Onko-Sure™ may become the first "pan tumor" marker in general widespread usage. Onko-Sure™ has international regulatory approvals as a general cancer marker in Taiwan, South Korea, Vietnam, India and Europe (CE Mark certification). In addition, Onko-Sure™ is approved for the detection and monitoring of lung cancer in Canada (Health Canada). In the US, Onko-Sure™ has been cleared to market as a colorectal cancer monitoring test.

Radient did not pay the annual fee to continue product registration with the FDA.

All patents for Onko Sure have now expired and the only patent application remaining has received a final rejection. The patent agent has resigned and there is no longer any current contact address for Radient Pharmaceuticals.

Telephone has been disconnected. website has been removed from service.

A website in Australia, is pending under construction since May 6, 2014.


With penalties and interest, Radient owes the 2011 lenders in excess of $25 million.




Class action lawsuit: Judge Grants Class Certification Over False Claims by Radient Pharmaceuticals

Insurance company settles class action lawsuit for $2.5 million.

Corporation has been voided by the state of Delaware.

All 5 billion shares authorized were issued.

All former management resigned and new management located in Australia were appointed.



#24675  Sticky Note William Gartner of GCDx denies any connection to RXPC. Gold Seeker 09/01/14 04:56:34 PM
#23693  Sticky Note RXPC revoked: Renee 07/03/14 09:31:11 AM
#21794  Sticky Note Please stay on topic . The only topic to IH Admin [Dan] 05/06/14 10:54:21 PM
#25409   agreed DC, WG needs to raise funds anyway livinginsv 09/20/14 08:32:10 PM
#25408   Very weak argument. dcspka 09/20/14 03:23:01 PM
#25407   DC, provista skipped this conference too . livinginsv 09/20/14 03:17:51 PM
#25406   GA, Good Point- no make that an excellent point: dcspka 09/20/14 02:53:22 PM
#25405   Now that makes sense. Gartner isn't paying for Gold Seeker 09/20/14 02:36:02 PM
#25404   The address you posted for the Iron Horse Gold Seeker 09/20/14 02:32:11 PM
#25403   Ahoooooo GOOD NEWS guardiangel 09/20/14 02:16:31 PM
#25402   Who really cares about William and GCDx? They GetSeriousOK 09/20/14 02:12:56 PM
#25401   perhaps, but bowser states a DIFFERENT address for livinginsv 09/20/14 02:02:50 PM
#25400   GCDX has an address in Tempe that is Gold Seeker 09/20/14 01:37:56 PM
#25399   provista is not developing a lung cancer test, livinginsv 09/20/14 12:50:03 PM
#25398   Living Said guardiangel 09/20/14 12:23:29 PM
#25397   GCDx shareholders don't think it's smoke and mirrors livinginsv 09/20/14 12:05:29 PM
#25396   DCMAN I remember when William fist trademarked "The Lung guardiangel 09/20/14 12:02:20 PM
#25395   Woofie, I will help you do some real DD. Gold Seeker 09/20/14 11:52:14 AM
#25394   So what you are saying is GCDX is guardiangel 09/20/14 11:48:40 AM
#25393   GA you said: GetSeriousOK 09/20/14 11:33:10 AM
#25392   Most people who use the &#153 never even Gold Seeker 09/20/14 11:25:48 AM
#25390   GETLS555 You Said guardiangel 09/20/14 10:54:23 AM
#25389   This pudding about secret patents contain no proof. GetSeriousOK 09/20/14 10:44:49 AM
#25388   Let's clear up the skepticism. GetSeriousOK 09/20/14 10:30:42 AM
#25387   Data from GoldLS post guardiangel 09/20/14 10:19:53 AM
#25386   DC The reason you are skeptical is guardiangel 09/20/14 10:10:15 AM
#25385   the Radient-Diagnostics site is WordPress. No company that GetSeriousOK 09/20/14 09:54:12 AM
#25383   Living you said guardiangel 09/20/14 09:38:03 AM
#25382   What is the Australian patent application number of GetSeriousOK 09/20/14 09:32:30 AM
#25381   Very Telling Indeed...Notice the skeptic hasn't posted that guardiangel 09/20/14 09:11:04 AM
#25380   Golde Said guardiangel 09/20/14 09:05:37 AM
#25379   Radient Pharmaceuticals does not have an active patent GetSeriousOK 09/20/14 08:49:41 AM
#25378   I think the most interesting info on the GetSeriousOK 09/20/14 08:39:13 AM
#25377   Woofie, do you know the difference between &#174 Gold Seeker 09/20/14 03:58:35 AM
#25376   GA- What is the significance of the AMDL dcspka 09/20/14 01:39:15 AM
#25373   the GCDx test was scheduled for 3/31/14 . livinginsv 09/20/14 01:08:29 AM
#25371   I think the most interesting info on the dcspka 09/20/14 12:59:29 AM
#25367   DCMAN About the GCDX web site..It did recently guardiangel 09/20/14 12:37:27 AM
#25366   GSOK, i disagree, both sites are intentionally sabotaged livinginsv 09/20/14 12:30:45 AM
#25365   Goldseeker you said guardiangel 09/20/14 12:23:46 AM
#25364   DCMAN You Said guardiangel 09/20/14 12:11:08 AM
#25363   Radient site is NOT "intentionally not up." GetSeriousOK 09/19/14 11:13:23 PM
#25362   any offer would have to be presented to livinginsv 09/19/14 10:23:02 PM
#25361   And the Radient Shareholders, market-wise savvy investors that GetSeriousOK 09/19/14 08:11:56 PM
#25360   Actually the next step is to let them dcspka 09/19/14 07:19:49 PM
#25359   GCDx site is not up- its a useless dcspka 09/19/14 07:17:56 PM
#25358   It's great that the wise men of this GetSeriousOK 09/19/14 06:37:45 PM
#25357   kumbaya, so what's the holdup? . . . livinginsv 09/19/14 05:21:48 PM
#25356   Tell me living, why do you think GCDx dcspka 09/19/14 05:06:53 PM
#25355   See Living, its a natural fit. dcspka 09/19/14 05:02:16 PM
#25354   Since SRL is an independent subsidiary, they are dcspka 09/19/14 04:49:59 PM
#25353   All of these patent applications would have lapsed Gold Seeker 09/19/14 04:48:04 PM
#25352   No Australian patents. They are all expired or lapsed. Gold Seeker 09/19/14 04:46:15 PM